2023 Speakers

Born to a poor immigrant family in New York City, Richard Carmona experienced homelessness, hunger, and health disparities during his youth. The experiences greatly sensitized him to the relationships among culture, health, education and economic status and ultimately shaped his future.

After dropping out of high school, Dr. Carmona enlisted in the U.S. Army in 1967 where he received a GED. By the time he left active duty, he was a Special Forces, combat-decorated Vietnam veteran. He then pursued a college degree and entered medical school at the University of California – San Francisco where he won the prestigious Gold Cane award as the top graduate.

Dr. Carmona became a surgeon with a sub-specialty in trauma, burns and critical care and was recruited to Tucson to establish the first trauma system in southern Arizona which he did successfully. Later, while working full time as a hospital and health system CEO, he earned a master’s degree in public health policy and administration at the University of Arizona.

Dr. Carmona has served for over 34 years with the Pima County Sheriff’s Department in Tucson, including as deputy sheriff, detective, SWAT team leader and department surgeon. He is one of the most highly decorated police officers in Arizona, and his numerous awards include the National Top Cop Award, the National SWAT Officer of the Year, and the National Tactical EMS Award. Dr. Carmona is a nationally recognized SWAT expert and has published extensively on SWAT training and tactics, forensics, and tactical emergency medical support. Dr. Carmona has also served as a medical director of police and fire departments and is a fully qualified peace officer with expertise in special operations and emergency preparedness, including weapons of mass destruction.

In 2006 Vice Admiral Carmona successfully completed the statutory four-year term as Surgeon General and was named vice chairman of Canyon Ranch, CEO of the health division and president of the Canyon Ranch Institute. Dr. Carmona continues his Canyon Ranch leadership role as the Chief of Health Innovations. He also serves on several public corporate boards and works with private equity and venture capital firms to identify emerging science and technology to translate to market for economic and public benefit.

Michelle A. Williams, SM ’88, ScD ’91, is Dean of the Faculty, Harvard T.H. Chan School of Public Health, and Angelopoulos Professor in Public Health and International Development, a joint faculty appointment at the Harvard Chan School and Harvard Kennedy School. She is an internationally renowned epidemiologist and public health scientist, an award-winning educator, and a widely recognized academic leader. Prior to becoming Dean, she was Professor and Chair of the Department of Epidemiology at the Harvard Chan School and Program Leader of the Population Health and Health Disparities Research Programs at Harvard’s Clinical and Translational Sciences Center. Dean Williams previously had a distinguished career at the University of Washington School of Public Health. Her scientific work places special emphasis in the areas of reproductive, perinatal, pediatric, and molecular epidemiology. Dean Williams has published more than 500 scientific articles and was elected to the National Academy of Medicine in 2016. In 2020, she was awarded the Ellis Island Medal of Honor and recognized by PR Week as one of the top 50 health influencers of the year. The Dean has an undergraduate degree in biology and genetics from Princeton University, a master’s in civil engineering from Tufts University, and master’s and doctoral degrees in epidemiology from the Harvard Chan School.

Gloria Caulfield leads health and wellness strategy and planning for the Lake Nona Institute. Gloria is passionate about identifying partners who are skillful at collaboration and have the desire to innovate solutions that have the potential to move the needle on community health and wellness.

David Cameron served as Prime Minister of the United Kingdom of Great Britain and Northern Ireland from 2010 to 2016, leading Britain’s first Coalition Government in nearly 70 years and, at the 2015 General Election, forming the first majority Conservative Government in the UK for over two decades.

David Cameron came to power in 2010 at a moment of economic crisis and with an unprecedented fiscal challenge. Under his leadership, the UK’s economy was transformed. The deficit was reduced by over two-thirds; one million businesses set-up; a record number of jobs were created: 1,000 extra jobs for every day he was Prime Minister; and Britain became the fastest-growing major advanced economy in the world.

Internationally, David Cameron developed a foreign policy in the post-Iraq era that addressed the new challenges of the Arab Spring, as well as a more aggressive Russia, while ensuring that Britain played a full role in the global fight against ISIS. Under his leadership, Britain built a strong partnership with India and became China’s preferred partner in the West. Throughout, David championed Britain’s special relationship with the US, working closely with President Barack Obama.

Following hosting the successful London 2012 Olympic and Paralympic Games, David chaired the 2013 G8 Summit at Lough Erne in Northern Ireland, where he highlighted the global need for fair taxes, increased transparency and open trade.

He led the way internationally by passing the UK’s Same Sex Marriage Act, enabling those who love each other to get married whatever their sexuality; settled the UK’s voting practices for a generation through the first of three national referenda held while he was in No10; and offered two more decisive national votes: the first on Scotland’s place within the United Kingdom; the second on the United Kingdom’s place within the European Union.

David fought both campaigns the only way he knew how, which was to say directly and passionately what he thought and believed was right – head, heart and soul. In winning the 2014 Scottish referendum he ensured Scotland remained part of the United Kingdom. However, despite arguing that Britain was stronger, safer and better off inside the European Union, in June 2016, the British people voted to leave the EU. Following this defeat, David resigned as Prime Minister and Leader of the Conservative Party, leaving 10 Downing Street on 13 July 2016.

During his leadership of the party, he promoted social justice and social action; advanced the green agenda; set protecting the NHS as a top priority; and was proud to see a significant increase in the number of women and ethnic minority candidates standing for the Conservative Party and elected to Parliament.

Since leaving 10 Downing Street, David has continued focusing on issues he advanced while in office: supporting life chances for young people and building a bigger, stronger society; championing Britain’s cutting edge medical research; and promoting international development.

David is Chairman of Patrons at National Citizen Service (NCS), the UK’s flagship youth development programme that brings together teenagers from all parts of the country for a part-residential experience.

He is also President of Alzheimer’s Research UK, Britain’s leading medical research charity with special focus on funding bio-medical research into the cause, prevention and cure of dementia.

And continuing the instrumental role he took while Prime Minister advocating UN Sustainable Development Goal 16, he has been working with the London School of Economics and Blavatnik School of Government at Oxford University by chairing the LSE-Oxford Commission on State Fragility, Growth and Development, under the auspices of the International Growth Centre. He also sits on the Global Board of Advisors at the Council on Foreign Relations and is a Board member of the ONE Campaign.

Further to these roles, David is advising and working with a number of international businesses, concentrating on technology, finance and medical innovation sectors.

Karmel Allison has spent more than 15 years working in ML and AI. She is currently a Technical Advisor in the Office of the CTO at Microsoft, helping to usher in an AI-enabled future across Microsoft and OpenAI, and in previous lives she led the TensorFlow Keras and Core APIs team at Google and received a PhD in Bioinformatics from the University of California, San Diego.

Jennifer is Senior Vice President, 5G Acceleration, Verizon Business. She is an experienced sales leader and general manager with an aptitude for creating diverse teams and fostering global perspectives.

She is responsible for catalyzing the adoption and commercialization of 5G across industries and enabling rapidly scalable deployment of 5G solutions to enterprises in the U.S. and around the world.

With keen knowledge of customers’ operations and unique needs, Jennifer and the 5G Acceleration Team use Verizon’s strength in building reliable networks and intelligent connectivity solutions to help businesses realize new capabilities, solve operational problems, and get to revenue faster.

Prior to joining Verizon Jennifer served as the President, BT in the Americas and MD, Technology, Life Sciences and Business Services where she led BT’s entire Americas team in the United States, Canada and Latin America and ran a global sales vertical focused on Technology, Life Sciences and Business Services customers. As the leader of one of three global vertical sales units, Artley built and grew relationships with BT’s top 800 customers in this ~£1.2B sales channel. She brought together the knowledge, resources, and skills of her global team to address customers’ complex digital transformations with insight, consistency, and agility.

Jennifer earned her Bachelor of Arts at Hobart and William Smith Colleges, her Master of Business Administration from University of Pennsylvania - Wharton School of Business, and her Master of Arts from The Lauder Institute at the University of Pennsylvania. She is fluent in Spanish and proficient in Russian. Jennifer was also a founding member and later an Advisory Board member of Minds Matter of Denver, a non-profit focused on mentoring and supporting unique educational opportunities for high achieving high school students from low income neighborhoods. Jennifer currently resides in Denver, Colorado with her husband and two daughters.

Founder of The Overtone Group, and former Chairman and CEO of Cardinal Health, a Fortune 20, multinational healthcare services company. Director of multiple corporate and nonprofit boards, visiting professor at NYU and Columbia University, musician, advisor on public policy issues, and mentor to senior executives and next generation of leaders. Recipient of multiple honors for a life dedicated to statesmanship and community service.

Iconic Grammy and Emmy Award-winning and Oscar-nominated artist, actress, producer, and entrepreneur Mary J. Blige is a figure of inspiration, transformation, and empowerment. With a track record of eight multi-platinum albums, nine Grammy Awards (37 nominations), an Emmy award, two Academy Award nominations, two Golden Globe nominations, and a SAG nomination, Blige has cemented herself as a global superstar.

Influenced at an early age by the music of Aretha Franklin, Chaka Khan and Gladys Knight, Blige brought her own gritty, urban-rooted style—fusing hip-hop, soul, and honest, frank lyrics—to the forefront on her 1992 debut album What’s the 411? Blige continued to redefine R&B and began forging a unique niche for herself on her second album, 1994’s My Life.

Each subsequent album she released reads like a chapter from an autobiography leading to February 2022, when Blige released her 15th studio album Good Morning Gorgeous, which has since earned her six 2023 Grammy nominations including Album and Record of the Year. The album release led into a historic performance at the Pepsi Super Bowl LVI Halftime Show at SoFi Stadium in Inglewood, CA alongside Dr. Dre, Eminem, Snoop Dogg, and Kendrick Lamar. Her performance earned her a 2022 Emmy Award for Outstanding Variety Special (Live).

Following the success of this performance, Blige and Pepsi announced the inaugural “Strength of a Woman Festival and Summit” in partnership with Live Nation Urban. The festival quickly sold out and will be back for its second year this May in Atlanta, GA.

On the acting side, Blige starred as Florence Jackson in the 2017 Netflix breakout film Mudbound, to which she received critical acclaim including two Academy Award nominations for Best Support Actress and Best Original Song. Among many other credits, Blige is currently starring in STARZ’s POWER BOOK II: GHOST, which will premiere its third season in March 2023.

On the producing side, Blige launched her production company, Blue Butterfly, and signed a first-look TV deal with Lionsgate. Blige also signed a first-look non-scripted deal and a second-look scripted deal with BET. In 2021, Blige worked with Oscar-winning filmmaker Vanessa Roth and Amazon on her documentary Mary J. Blige's My Life celebrating the 25th anniversary of her famed album My Life, of which she was the focus and EP.

David Blumenthal is President Emeritus of the Commonwealth Fund and was previously Chief Health Information and Innovation Officer at Partners Health System, and Samuel O. Thier Professor of Medicine and Professor of Health Care Policy at Massachusetts General Hospital/ Harvard Medical School. He was National Coordinator for Health Information Technology under President Barack Obama from 2009-2011.

Barbara Bouza is president of Walt Disney Imagineering, where she heads the global creative, design and development teams behind Disney’s theme parks, attractions, resort hotels, cruise ships, and retail, dining and entertainment centers. She also leads a multidisciplinary team tasked with exploring, developing and bringing to market groundbreaking ideas that enhance and expand Disney’s portfolio of experiences around the world.

Barbara previously served as co-managing director, principal, of Gensler Los Angeles. A fellow of the American Institute of Architects (AIA), she was the 2019 AIA Los Angeles president, and also served on the board of the Southern California chapter of the International Interior Design Association.

Barbara is on the board of directors of Imagine LA, a leading not-for-profit dedicated to mobilizing the community to end the cycle of family homelessness and poverty, and is a member of the National Organization of Minority Architects and the Women Presidents’ Organization. Additionally, she works with nonprofit organizations such as Girls Inc. and Dress for Success.

Barbara holds a Bachelor of Architecture degree from California State Polytechnic University, Pomona, and studied in the Graduate Diploma Program at the Architectural Association in London.

John Hope Bryant is an American entrepreneur, author, philanthropist, and prominent thought leader on financial inclusion, economic empowerment and financial dignity. He has served as an advisor to the last three sitting U.S. presidents, from both political parties. He is responsible for financial literacy becoming the policy of the U.S. federal government. Additionally, Bryant is a permanent part of the Smithsonian AFRICAN-American Museum. He is named one of Atlanta Business Chronicle’s “Most Admired CEOs” in 2018, American Banker magazine “Innovator of the Year” in 2016, Inc. Magazine “The World’s 10 Top CEOs”, and in 1994 Time magazine’s “50 Leaders for the Future”.

Sebastien Bubeck is a Senior Principal Research Manager in the Machine Learning Foundations group at Microsoft Research (MSR). He joined the Theory Group at MSR in 2014, after three years as an assistant professor at Princeton University. His works on convex optimization, online algorithms and adversarial robustness in machine learning received several best paper awards (NeurIPS 2021 best paper, NeurIPS 2018 best paper, ALT 2018 best student paper in joint work with MSR interns, COLT 2016 best paper, and COLT 2009 best student paper). Recently he has been focused on exploring a physics-like theory of neural networks learning.

Lauren Bush Lauren is the Founder and CEO of FEED, an impact-driven brand founded upon the belief that food is a universal human right. Every FEED product sold provides school meals to children through direct donations to our on-the-ground partners. Since 2007, FEED has helped provide over 126 million school meals around the world and here in the U.S.

For her work with FEED, Lauren has received multiple awards, including Fortune Magazine’s Most Powerful Women Entrepreneurs in 2009 and Inc. Magazine’s 30 Under 30 in 2010. In 2015, she was named a World Economic Forum Young Global Leader. Lauren resides in New York City where she also serves on the Board of Directors for the Food Bank for NYC. Outside of work, Lauren’s most important role is as Mama to three boys – James, Max, and Rocky.

Dr Mobasher Butt has 20 years of international experience as a senior physician executive and clinical practitioner. He was previously the Global Medical Vice-President at Babylon, a leading healthcare organisation. Prior to this Mobasher held roles at the World Health Organisation, British Medical Journal, NHS London and the UK Department of Health. Mobasher has disrupted healthcare globally by building and deploying cutting edge AI solutions and digital health services in 17 countries. He was pivotal in developing Babylon’s business from a pre-series start-up to IPO valued at $4.2 billion dollars. Mobasher has collaborated with governments, regulators and commercial partners worldwide.

As a primary care physician, Mobasher has focused his career on improving healthcare through innovation. As a partner in the NHS GP at Hand service, he established a ground-breaking digital primary care service, which was both the first service of its kind in the UK NHS’ 70 year history and one of the fastest growing NHS services ever. Mobasher was named the most influential GP in the UK in 2018 and has extensive clinical experience in the UK and overseas, in both developed and developing country settings. He holds an MPH from the London School of Hygiene and Tropical Medicine, an MD from University College London, and a Healthcare Management BSc (Hons) from Imperial College London.

Robin is the Ralph Metzner Distinguished Professor in Neurology and Psychiatry and Director Neuroscape’s Psychedelics Division at the University of California, San Francisco. He moved to Imperial College London in 2008 after obtaining a PhD in Psychopharmacology. Robin has designed human brain imaging studies with LSD, psilocybin, MDMA and DMT, and clinical trials of psilocybin therapy for severe mental illnesses.

Juju Chang is an Emmy® Award-winning co-anchor of ABC News’ “Nightline.” She also reports regularly for “Good Morning America” and “20/20.” Chang reported on the recent rise of hate crimes toward the Asian American and Pacific Islander (AAPI) community as anchor of the ABC News Live special “Stop The Hate: The Rise In Violence Against Asian Americans” and the “20/20” special “Murder In Atlanta” following the Atlanta mass shooting.

Chang has been recognized for her in-depth personal narratives set against the backdrop of pressing national and international news. Her recent reports include a critical examination of the controversial Migrant Protection Protocols (MPP) known as the “Remain in Mexico” immigration policy. The story was told through the eyes of one pregnant woman and her family among the 60,000 asylum seekers camped for months along the Rio Grande. Chang’s award-winning report on violence against transgender women of color across the country caps a series of her stories on LGBTQ+ issues. Chang won a GLAAD award for her story on the 25th anniversary of Matthew Shepard’s murder and the legacy his parents have built in his honor. Chang’s exclusive television interview with transgender solider Chelsea Manning, after seven years in prison, explored issues of national security leaks, medical treatment for incarcerated transgender people and LGBTQ+ military service.

Chang has covered the major breaking news for decades for ABC News, including the extensive COVID-19 science and the fallout on hospital ICU’s, health care and essential workers. Chang covered Superstorm Sandy, the Orlando nightclub massacre and the Boston Marathon bombing.

She has traveled around the world to report on global issues and gender-based violence, including a trip through Central Africa on the front lines against Boko Haram and #bringbackourgirls. She traveled to Honduras for “Femicide: the Untold War,” an eye-opening look at rampant violence against women.

Chang has profiled newsmakers like Facebook COO Sheryl Sandberg, former Vice President Joe Biden and Oprah Winfrey as well as entertainers like Chris Pratt, Channing Tatum, Tom Hanks and Nicki Minaj. Her extensive feature reporting covers parenting dilemmas, digital addictions and social media moguls like Dude Perfect and Kendall Jenner.

A former news anchor for “Good Morning America,” Chang joined ABC News just after college as an entry-level desk assistant in 1987 and rose to become a producer for “World News Tonight.” After reporting for KGO-TV in San Francisco and the ABC News affiliate service NewsOne in Washington, D.C., she co-anchored the overnight show “World News Now.” Chang’s work has been recognized with numerous awards, including multiple Emmy’s, Gracie’s, a DuPont, a Murrow and Peabody awards. In 2017, she was honored with the Lifetime Achievement Award at the Front Page Awards.

Born in Seoul, South Korea, and raised in Northern California, Chang graduated with honors from Stanford University with a Bachelor of Arts in political science and communication. She is married to WNET president and CEO Neal Shapiro and, together, they have three sons. Chang is a member of the Council on Foreign Relations and a founding board member of the Korean American Community Foundation.

Chaplain Clementina Chéry is the Founder, President & CEO of the Louis D. Brown Peace Institute in Boston, Massachusetts. The Peace Institute is a center of healing, teaching, and learning for families and communities impacted by murder, trauma, grief, and loss. Chaplain Chéry and her family founded the Peace Institute in 1994 after her 15-year-young son Louis D. Brown was murdered in the crossfire of a shootout.

Chaplain Chéry has developed the best practices in the field of homicide response. Her professional goal is to transform society’s response to homicide so that all families are treated with dignity and compassion, regardless of the circumstances. Her spiritual goal is to become a Minister of God’s Peace that is rooted in love, unity, faith, hope, courage, justice, and forgiveness.

Chaplain Chéry has extensive experience training public health professionals, law enforcement officials, and faith leaders to better serve families impacted by murder. She has trained members of the Miami Police Department Homicide Unit to respond equitably and effectively to homicide, and convened the first-ever Homicide Response Briefing in Massachusetts for over 100 law enforcement officials from across the state. She has also led trainings for the Massachusetts Office of Victim Assistance.
She has also trained doctors, social workers, psychologists, street workers, and other providers at city and state agencies, hospitals, and community-based organizations.

Her groundbreaking publications for families of murder victims and the providers who serve them include “Always in My Heart: A Workbook for Grieving Children” (2011) and the Survivors Burial and Resource Guide (2013). The Survivors Burial and Resource Guide offers step-by-step guidance to families of murder victims. Chaplain Chéry is also coauthor of an article entitled “Homicide Survivors: Research and Practice Implications,” which was published in the American Journal of Preventive Medicine in 2005.

In 2023, she launched The Peace Principle, a podcast where she leads conversations on ways to heal our wounded hearts.

Chaplain Chéry received an honorary Doctorate of Ministry from the College of the Holy Cross in Worcester, Massachusetts and was ordained as a senior chaplain with the International Fellowship of Chaplain, Inc. in 2012.

Her greatest accomplishments are being the mother of Louis, Alexandra and Allen, and the grandmother of Alexander, Adriel, and Amani.

As vice chair of the Clinton Foundation, Chelsea Clinton works alongside the Foundation’s leadership and partners to improve lives and inspire emerging leaders across the United States and around the world. This includes the Foundation’s early child initiative Too Small to Fail, which supports families with the resources they need to promote early brain and language development; and the Clinton Global Initiative University (CGI U), a global program that empowers student leaders to turn their ideas into action. A longtime public health advocate, Chelsea also serves as vice chair of the Clinton Health Access Initiative and uses her platform to increase awareness around issues such as vaccine hesitancy, childhood obesity, and health equity.

In addition to her Foundation work, Chelsea teaches at Columbia University’s Mailman School of Public Health and has written several books for young readers, including the #1?New York Times bestseller?She Persisted: 13 American Women Who Changed the World?as well as?She Persisted Around the World,?She Persisted in Sports,?She Persisted in Science, Start Now! You Can Make a Difference;?Don’t Let Them Disappear; It’s Your World: Get Informed, Get Inspired & Get Going; and Welcome to the Big Kids Club.?She is also the co-author of?The Book of Gutsy Women?and?Grandma’s Gardens?with Secretary Hillary Rodham Clinton and of?Governing Global Health: Who Runs the World and Why??with Devi Sridhar. Chelsea’s podcast, In Fact with Chelsea Clinton, premiered in 2021 and is the co-founder of HiddenLight Productions.

Chelsea holds a Bachelor of Arts from Stanford, a Master of Public Health from Columbia's Mailman School of Public Health, and both a Master of Philosophy and a Doctorate in international relations from Oxford University. She lives with her husband Marc, their children Charlotte, Aidan and Jasper, and dog Soren in New York City.

Robin Cogan, MEd, RN, NCSN, FNASN, FAAN is a New Jersey school nurse in the Camden City School District. Robin is the Director from NJ for the National Association of School Nurses. She is on faculty at Rutgers University-Camden School of Nursing. Robin writes a popular blog called The Relentless School Nurse. Her extensive career in school nursing was included as a case study in the National Academies of Medicine Future of Nursing 2030 report. Follow Robin on Twitter @RobinCogan

Josh Cohen co-founded Amylyx Pharmaceuticals in 2013 and has served since that time as its Co-CEO and Co-Founder. Josh co-invented AMX0035 and has overseen the growth of Amylyx from its start as a concept dreamed up in a dorm room to its status now as a pre-commercial stage pharmaceutical company. Together with Justin, Josh has raised nearly $250M in financing to support the development of new therapies for ALS and other neurodegenerative diseases. Josh received his Bachelor of Science in Biomedical Engineering from Brown University.

Francis S. Collins, M.D., Ph.D., currently serves as the Special Advisor to President Biden for Special Projects. In this role, he is leading a bold program to help eliminate Hepatitis C in the United States. Dr. Collins also maintains his longstanding position as a Senior Investigator in the intramural program of the National Human Genome Research Institute, pursuing genomics research on type 2 diabetes and a rare disorder of premature aging called progeria.

Dr. Collins previously served as the 16th Director of the National Institutes of Health (NIH), appointed by President Barack Obama and confirmed by the Senate in 2009. In 2017, President Donald Trump asked Dr. Collins to continue to serve as the NIH Director. President Joe Biden did the same in 2021. For those 12 years, serving an unprecedented three administrations, Dr. Collins oversaw the work of the largest supporter of biomedical research in the world, spanning the spectrum from basic to clinical research. Dr. Collins stepped down as Director on December 19, 2021.

Dr. Collins is a physician-geneticist noted for his landmark discoveries of disease genes and his previous leadership of the international Human Genome Project, which culminated in April 2003 with the completion of a finished sequence of the human DNA instruction book. He served as director of the National Human Genome Research Institute at NIH from 1993-2008.

Dr. Collins is an elected member of both the National Academy of Medicine and the National Academy of Sciences, was awarded the Presidential Medal of Freedom in November 2007, and received the National Medal of Science in 2009. In 2020, he was elected as a Foreign Member of the Royal Society (UK) and was also named the 50th winner of the Templeton Prize, which celebrates scientific and spiritual curiosity.

Dr. Kizzmekia S. Corbett is an assistant professor of immunology and infectious diseases at Harvard’s T.H. Chan School of Public Health, Shutzer Assistant Professor at Harvard’s Radcliff Institute of Advanced Study, and Associate Member of the Phillip T. and Susan M. Ragon Institute. Dr. Corbett’s laboratory studies host immune responses to coronaviruses and other emerging and re-emerging viruses to propel novel vaccine and antibody therapy development. In 2008, she received a BS in Biological Sciences, with a secondary major in Sociology, from the University of Maryland – Baltimore County, where she was a Meyerhoff Scholar and NIH undergraduate scholar. She then obtained her PhD in Microbiology and Immunology in 2014 from the University of North Carolina at Chapel Hill holding multiple honors, including a director’s scholarship. Prior to Harvard, she was a research fellow and scientific lead at the National Institute of Allergy and Infectious Diseases Vaccine Research Center. A leading COVID-19 vaccine, mRNA-1273, was co-designed by Dr. Corbett’s NIH team from viral sequence and rapidly deployed to industry partner, Moderna, Inc., for Phase 1 clinical trial, which unprecedently began only 66 days from viral sequence release. mRNA-1273 is a now used around the world to prevent COVID-19 disease. Alongside mRNA-1273, Dr. Corbett boasts a patent portfolio which also includes universal coronavirus and influenza vaccine concepts and novel therapeutic antibodies. In all, she has over 15 years of experience studying dengue virus, respiratory syncytial virus, influenza virus, and coronaviruses, garnering several prestigious awards and recognitions, such as being named a Time Magazine “Hero of the Year” in 2021. Combining her research goals with her knack for mentorship, Dr. Corbett invests much of her time in underserved communities as an advocator of STEM education and vaccine awareness.

Katie Couric (@katiecouric) is an award-winning journalist and #1 New York Times best-selling author of her memoir, Going There, which was published in October 2021. She is also a co-founder of Stand Up To Cancer (SU2C) which has raised more than $700 million for cancer research.

Couric was the first woman to solo anchor a network evening newscast, serving as anchor and managing editor of the CBS Evening News from 2006 to 2011 following 15-years as co-anchor of NBC’s Today show.

In 2017, she founded Katie Couric Media (KCM), which has developed a number of media projects, including a daily newsletter, “Wake-Up Call”, a podcast, “Next Question”, digital video series and several documentaries. You can find it all at katiecouric.com.

John F. Crowley is the Executive Chairman of Amicus Therapeutics, a global biotechnology company focusing on developing treatments for rare genetic diseases. He served as Chief Executive Officer of Amicus from 2005 to 2022. John’s involvement with biotechnology stems from the 1998 diagnosis of two of his children with Pompe disease—a severe and often fatal neuromuscular disorder. In his drive to find a cure for them, he left his position at Bristol-Myers Squibb and became an entrepreneur as the Co-founder, President and CEO of Novazyme Pharmaceuticals, a biotech start-up conducting research on a new experimental treatment for Pompe disease (which he credits as ultimately saving his children’s lives). In 2001, Novazyme was acquired by Genzyme Corporation and John continued to play a lead role in the development of a drug for Pompe disease as Senior Vice President, Genzyme Therapeutics.

John and his family have been profiled numerous times on the front page of The Wall Street Journal and are the subjects of a book by Pulitzer prize-winning journalist Geeta Anand, “The Cure: How a Father Raised $100 Million-And Bucked the Medical Establishment-In a Quest to Save His Children.” The major motion picture, Extraordinary Measures, starring Brendan Fraser and Harrison Ford, is inspired by the Crowley family journey. John is the author of a personal memoir: Chasing Miracles: The Crowley Family Journey of Strength, Hope, and Joy.

John served as a commissioned officer in the U.S. Navy Reserve from 2005-2016, assigned to the United States Special Operations Command, and is a veteran of the global war on terrorism, with service in Afghanistan. He graduated with a B.S. in Foreign Service from Georgetown University and earned a J.D. from the University of Notre Dame Law School and an M.B.A. from Harvard. The Crowley family was the recipient of the 2011 Family Exemplar Award from the University of Notre Dame. He is also a member of the University Council on Science & Technology at Notre Dame. Currently, John serves as a member of the Board of Directors of Intellia Therapeutics, Inc. and Entrada Therapeutics, Inc. He is the former National Chairman of the Make-A-Wish Foundation of America and is a founding Board member of the Global Genes Project. John is a Henry Crown Fellow at the Aspen Institute. He was awarded a Doctor of Laws Degree (Honoris Causa) from the University of Notre Dame, where he delivered the commencement address to the Class of 2020.

Academy Award winner Geena Davis is one of Hollywood’s most respected actors, appearing in several roles that became cultural landmarks.

Davis received her first Academy Award, for Best Supporting Actress, for her role as the offbeat dog trainer Muriel Pritchett in Lawrence Kasdan’s The Accidental Tourist. She was again nominated for an Academy Award and Golden Globe for her performance in Ridley Scott’s Thelma & Louise, in which she co-starred with Susan Sarandon.

In 2019 Davis was honored with a second Oscar, this time the Academy’s Jean Hersholt Humanitarian Award, in recognition of the work Davis has done over the decades to achieve gender parity onscreen in film and television.

Earning the 2006 Golden Globe Award for Best Performance by an Actress in a Television Series – Drama, Davis broke ground in her portrayal of the first female President of the United States in ABC’s hit show Commander in Chief.

Davis made her feature film debut starring opposite Dustin Hoffman in Tootsie. She went on to star in such films as The Fly, Beetlejuice, The Long Kiss Goodnight, Stuart Little, and A League of Their Own.

Few have achieved such remarkable success in as many different fields as Davis has: she is not only an Oscar and Golden Globe-winning actor, but a world-class athlete (at one time the nation’s 13th-ranked archer), a member of the genius society Mensa, and is now recognized for her tireless advocacy of women and girls nearly as much as for her acting accomplishments. She is the Founder and Chair of the non-profit Geena Davis Institute on Gender in Media, which engages film and television creators to dramatically increase the percentage of female characters — and reduce gender stereotyping — in media made for children 11 and under.

Davis also serves as the Chair of the Bentonville Film Festival Foundation a year-long initiative focused on promoting underrepresented voices of diverse storytellers in entertainment and media through research, education, and supporting the production and distribution of inclusive content.

Davis is an Executive Producer on the Gracie Award winning feature film This Changes Everything and Emmy nominated, People’s Choice and Gracie Award winning television show Mission Unstoppable on CBS.

Davis holds honorary degrees from Boston University, Bates College, and New England College

Rick Doblin, Ph.D., is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master’s thesis on a survey of oncologists about smoked marijuana vs. the oral THC pill in nausea control for cancer patients. His undergraduate thesis at New College of Florida was a 25-year follow-up to the classic Good Friday Experiment, which evaluated the potential of psychedelic drugs to catalyze religious experiences. He also conducted a thirty-four year follow-up study to Timothy Leary’s Concord Prison Experiment. Rick studied with Dr. Stanislav Grof and was among the first to be certified as a Holotropic Breathwork practitioner. His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist. He founded MAPS in 1986, and currently resides in Boston with his wife and puppy, with three empty rooms from his children whom have all graduated college and begun their life journeys.

Victor J. Dzau is the President of the US National Academy of Medicine (NAM). In addition, he serves as Vice Chair of the US National Research Council. He is Chancellor Emeritus and James B. Duke Professor of Medicine at Duke University and the past President and CEO of the Duke University Health System.

Todd is a KPMG advisory principal focused on the healthcare industry. He also serves as the MidSouth Advisory Hub Leader, responsible for people and partner connectivity and supporting community and philanthropic initiatives. With over 20 years’ experience working with payors and providers across the country and globally, Todd has particular strengths in Health Equity, EHR design and implementation, intelligent automation, large scale IT system transformation, population health management, Medicaid IT transformation and enterprise transformation. Todd has authored numerous thought leadership papers on health equity, and leads KPMG’s support to large healthcare providers and medical schools as they deploy a data-led approach to identifying and addressing health inequity in their communities and nationally.

Todd is an active member in the Atlanta community, serving as a board member for CHRIS 180 which assists homeless youth in Atlanta, a Leadership Atlanta Alumnus (2018), a member of 100 Black Men of Atlanta, a board member of the Atlanta Opera and a member of the Grady Hospital Ambassador Force which focuses on serving and ensuring underrepresented populations receive the best medical care possible.

Mick Farrell is CEO of ResMed, the global leader in digital health for respiratory medicine and residential medicine, with 19 million 100%-cloud-connectable medical devices in 140 countries. Mick serves on the board of directors for ResMed, Zimmer Biomet, and AdvaMed. He was educated at MIT and volunteers for non-profits, including Father Joe’s Village for homeless residents in San Diego, California.

As Chairman of Oracle Health, David Feinberg, M.D., is committed to making healthcare more accessible, affordable and equitable. Previously served as president/CEO of Cerner (now Oracle Health), UCLA Health and Geisinger Health, leader at Google Health and early career as pediatric psychiatrist. He has his M.D. from Chicago Medical School, an economics degree from the University of California-Berkeley and an MBA from Pepperdine University.

Pat Geraghty is President and Chief Executive Officer of GuideWell, a $26 billion mutual insurance holding company headquartered in Jacksonville, Fla. A mission-driven health solutions enterprise, GuideWell is the parent to a family of forward-thinking companies focused on transforming health care.

GuideWell comprises Florida Blue, Florida’s Blue Cross Blue Shield plan and leading health insurance company in Florida; Triple-S Management, Puerto Rico’s Blue Cross Blue Shield plan and leading health care services company in Puerto Rico; GuideWell Health, a portfolio of clinical delivery organizations; GuideWell Venture Group, a portfolio of companies, including PopHealthCare, focused on creating human-first and innovative health solutions for health plans; GuideWell Source, a provider of administrative services to state and federal health care programs; and WebTPA, a market leading administrator of self-funded employer health plans. GuideWell serves more than 46 million people across 45 states, Puerto Rico and the U.S. Virgin Islands, including more than 6 million individuals in Florida.

Geraghty was the architect of the strategic restructuring that created GuideWell from the foundation of a more than 75-year-old health insurance company, transforming it into a health solutions organization at the forefront of reimagining the future of health.

Geraghty is considered an expert voice on a range of health care topics including health care reform, next-generation payment strategies, innovation in health care and the benefits of wellness and prevention programming. He is frequently sought after for his insights on important health care policy matters in Washington, D.C. and Tallahassee, Fla.

He is a member of the Florida Council of 100 and serves on the boards of the Blue Cross Blue Shield Association, including chair of its Health Policy & Advocacy Committee, National Institute of Health Care Management; America’s Health Insurance Plans; and Tampa Electric Co. His work with United Way, MaliVai Washington Youth Foundation and American Cancer Society are also among his most important commitments.

Geraghty holds a Bachelor of Arts degree from Colgate University and a Doctor of Humane Letters, honoris causa, degree from Florida Southern College. He also has completed executive education programs at Harvard University School of Public Health and the Wharton School at the University of Pennsylvania.

Carey Goldberg is co-author (with Peter Lee and Zak Kohane) of the upcoming book “The AI Revolution in Medicine,” to be published by Pearson in April. Carey is a longtime medical and science journalist who has covered a broad gamut of health-related topics, from costs of care to life science research. She has been the Boston bureau chief of Bloomberg News and of The New York Times, and has reported on health and science for The Boston Globe and WBUR/NPR. In her earlier career, she was a staff Moscow correspondent for The Los Angeles Times, covering the collapse of the Soviet Union and the stormy period that followed. Carey has won multiple journalism prizes, including an Edward R. Murrow award for media innovation, and spent a year as a Knight Science Journalism Fellow at MIT. She co-authored a 2010 memoir from Little, Brown, “Three Wishes: A True Story of Good Friends, Crushing Heartbreak and Astonishing Luck on Our Way To Love and Motherhood.”

Lori F. Gooding, PhD, MT-BC, is Associate Professor of Music Therapy at Florida State University and President of the American Music Therapy Association. Her research interests include music therapy in biopsychosocial and family-centered care, and she has published and presented nationally and internationally. Dr. Gooding recently completed a Fulbright grant to Malaysia where she worked with colleagues from the Universiti Putra Malaysia to build the foundation for the first music therapy degree program in the country.

Robert Green, MD, MPH is a board-certified medical geneticist and Professor of Medicine at Harvard Medical School who directs the Genomes2People Research Program at Mass General Brigham, Ariadne Labs and the Broad Institute.

Dr. Green’s empirical research and policy development is accelerating the implementation of genomic and precision medicine. His work has established the safety and feasibility of disclosing various forms of genetic risk information, assessed the impact of whole genome sequencing in primary care, created the concept of aggregate penetrance of genomic variants in a prospective population cohort and provided early data on the clinical utility and cost-effectiveness of genomic sequencing in healthy adults (the MedSeq Project), and in active duty military personnel (the MilSeq Project). Most recently Dr. Green is leading the first empirical trial of comprehensive sequencing in healthy newborn infants, the NIH-funded BabySeq Project.

Dr. Green established the world’s first academically-affiliated, family-oriented Preventive Genomics Clinic in Boston and led policy development for returning genomic information to research participants within the Global Alliance for Genomics and Health, the Verily-Google Baseline Project and All of Us Research Program. In 2017, he co-founded the nationwide telegenetics company Genome Medical.

Dr. Sanjay Gupta is the multiple Emmy®-award winning chief medical correspondent for CNN and host of the CNN podcast Chasing Life. Gupta, a practicing neurosurgeon, plays an integral role in CNN's reporting on health and medical news for all of CNN's shows domestically and internationally, and regularly contributes to CNN.com.

In addition to his work for CNN, Gupta is an associate professor of neurosurgery at Emory University Hospital and associate chief of neurosurgery at Grady Memorial Hospital in Atlanta. He serves as a diplomate of the American Board of Neurosurgery. And in 2019, Gupta was elected to the National Academy of Medicine, considered one of the highest honors in the medical field.

In 2021, Gupta co-founded the LIFE ITSELF conference with Marc Hodosh of TEDMED.